Pfizer Seeks To Nearly Double Shares Of Indian Pfizer Arm
This article was originally published in PharmAsia News
Executive Summary
U.S.-based Pfizer, which already owns 41.2 percent of its Indian subsidiary, Pfizer Ltd., is offering to buy another 33.8 percent to give it 75 percent ownership. The $136 million offer by Pfizer tracks a similar move just weeks earlier by Swiss drug maker Novartis, which sought to increase control of its Indian unit, Novartis India. If Indian regulators approve, Pfizer's offer to shareholders is expected to open in June. (Click here for more